Department of Urology, Gaozhou People's Hospital, Gaozhou, Guangdong, China.
Department of Urology, Gaozhou People's Hospital, Gaozhou, Guangdong, China.
Urology. 2019 Sep;131:14-20. doi: 10.1016/j.urology.2019.03.034. Epub 2019 May 24.
Transurethral resection of prostate (TURP) still remains the "gold standard" surgical treatment for benign prostatic hyperplasia (BPH). In recent years, holmium laser enucleation of prostate (HoLEP) gets more and more popularity in the world. Our objective is to compare the efficacy and safety of HoLEP and TURP for BPH. Eleven studies met our eligibility criteria including 1339 patients. The prostate sizes of the all included studies were smaller than 100 g. Overall, in patients with small to mid-sized prostates, HoLEP offers safer clinical outcomes with less blood drop and potentially better long-term relief of bladder outlet obstruction.
经尿道前列腺切除术(TURP)仍然是治疗良性前列腺增生症(BPH)的“金标准”手术方法。近年来,钬激光前列腺剜除术(HoLEP)在世界范围内越来越受欢迎。我们的目的是比较 HoLEP 和 TURP 治疗 BPH 的疗效和安全性。符合纳入标准的研究共有 11 项,共纳入 1339 例患者。所有纳入研究的前列腺体积均小于 100g。总体而言,对于前列腺体积较小或中等的患者,HoLEP 具有更安全的临床结局,出血量更少,长期缓解膀胱出口梗阻的效果可能更好。